This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Triaminic - Cold, Cough and Fever

Starting date:
January 31, 2013
Posting date:
March 1, 2013
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-23793

Recalled Products

A. Triaminic - Cold, Cough and Fever

Reason

The child-resistant feature of the bottle cap may not function properly, enabling the cap to be removed when the tamper-evident seal is still in place.

Depth of distribution

Wholesalers and pharmacies across Canada.

Affected products

A. Triaminic - Cold, Cough and Fever

DIN, NPN, DIN-HIM
DIN 02239666
Dosage form

Syrup

Strength
  • Acetaminophen 160 mg/5 mL
  • Pseudoephedrine Hydrochloride 15 mg/5 mL
  • Dextromethorphan Hydrobromide 7.5 mg/5 mL
  • Chlorpheniramine Maleate 1 mg/5 mL
Lot or serial number

All lots with expiry dates up to June 2013

Companies
Recalling Firm
Novartis Consumer Health Canada Inc.
Suite 205, West Tower 2233 Argentia Road
Mississauga
L5N 2X7
Ontario
CANADA
Marketing Authorization Holder
Novartis Consumer Health Canada Inc.
Suite 205, West Tower 2233 Argentia Road
Mississauga
L5N 2X7
Ontario
CANADA

Date modified: